Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Putter, H."'
Autor:
Hagenaars, S.C., Groot, S. de, Cohen, D., Dekker, T.J.A., Charehbili, A., Kranenbarg, E.M.K., Carpentier, M.D.D., Pijl, H., Putter, H., Tollenaar, R.A.E.M., Kroep, J.R., Mesker, W.E., Dutch Breast Can
Publikováno v:
International Journal of Cancer, 149(5), 1181-1188. WILEY
International Journal of Cancer
International Journal of Cancer
The tumor‐stroma ratio (TSR) has proven to be a strong prognostic factor in breast cancer, demonstrating better survival for patients with stroma‐low tumors. Since the role of the TSR as a predictive marker for neoadjuvant chemotherapy outcome is
Autor:
Groot, S. de, Lugtenberg, R.T., Cohen, D., Welters, M.J.P., Ehsan, I., Vreeswijk, M.P.G., Smit, V.T.H.B.M., Graaf, H. de, Heijns, J.B., Portielje, J.E.A., Wouw, A.J. van de, Imholz, A.L.T., Kessels, L.W., Vrijaldenhoven, S., Baars, A., Kranenbarg, E.M.K., Duijm-de Carpentier, M., Putter, H., Hoeven, J.J.M. van der, Nortier, J.W.R., Longo, V.D., Pijl, H., Kroep, J.R., Goker, E., Pas, A.J.M., Honkoop, A.H., Dutch Breast Canc Res Grp BOOG
Publikováno v:
Nature Communications, 11
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
Nature Communications, 11(1). NATURE PUBLISHING GROUP
Nature Communications, 11, 1
Nature Communications
Nature Communications, Vol 11, Iss 1, Pp 1-9 (2020)
Nature Communications, 11(1). NATURE PUBLISHING GROUP
Nature Communications, 11, 1
Nature Communications
Short-term fasting protects tumor-bearing mice against the toxic effects of chemotherapy while enhancing therapeutic efficacy. We randomized 131 patients with HER2-negative stage II/III breast cancer, without diabetes and a BMI over 18 kg m−2, to r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::906599da7dc475c6bbe7b08453119143
https://hdl.handle.net/1887/3181368
https://hdl.handle.net/1887/3181368
Autor:
Charehbili, A., Hamdy, N.A.T., Smit, V.T.H.B.M., Kessels, L., Bochove, A. van, Laarhoven, H.W. van, Putter, H., Kranenbarg, E.M.K., Leeuwen-Stok, A.E. van, Hoeven, J.J.M. van der, Velde, C.J.H. van de, Nortier, J.W.R., Kroep, J.R., Dutch Breast Canc Res Grp BOOG
Publikováno v:
Breast, 25, pp. 69-74
The Breast, 25, 69-74
Breast (Edinburgh, Scotland), 25, 69-74. Churchill Livingstone
Breast, 25, 69-74
The Breast, 25, 69-74
Breast (Edinburgh, Scotland), 25, 69-74. Churchill Livingstone
Breast, 25, 69-74
Item does not contain fulltext BACKGROUND: Serum levels of 25-OH vitamin D3 (vitamin D) have been shown to be prognostic for disease-free survival in patients with breast cancer. We investigated the predictive value of these levels for pathological r
Autor:
Charehbili, A., Ven, S. van de, Smit, V.T.H.B.M., Kranenbarg, E.K., Hamdy, N.A.T., Putter, H., Heijns, J.B., Warmerdam, L.J.C. van, Kessels, L., Dercksen, M., Pepels, M.J., Maartense, E., Laarhoven, H.W.M. van, Vriens, B., Wasser, M.N., Leeuwen-Stok, A.E. van, Liefers, G.J., Velde, C.J.H. van de, Nortier, J.W.R., Kroep, J.R., Dutch Breast Canc Res Grp BOOG
Publikováno v:
Annals of Oncology, 25, 5, pp. 998-1004
Annals of Oncology, 25(5), 998-1004. Oxford University Press
Annals of oncology, 25(5), 998-1004. Oxford University Press
Annals of Oncology, 25(5), 998-1004
Annals of Oncology, 25, 998-1004
Annals of Oncology, 25(5), 998-1004. Oxford University Press
Annals of oncology, 25(5), 998-1004. Oxford University Press
Annals of Oncology, 25(5), 998-1004
Annals of Oncology, 25, 998-1004
Item does not contain fulltext BACKGROUND: The role of zoledronic acid (ZA) when added to the neoadjuvant treatment of breast cancer (BC) in enhancing the clinical and pathological response of tumors is unclear. The effect of ZA on the antitumor effe